Saliva Diagnostic Systems
This article was originally published in The Gray Sheet
Executive Summary
Introduces SalivaCheck rapid saliva diagnostic test for determining whether a sample "is truly saliva" by detecting Immunoglobulin G with a "litmus paper-type strip." SDS has received an order for the test from Diagnostic Technology Company, a London-based insurance testing facility. SDS is expanding the SalivaCheck format to areas such as HIV, H. Pylori, hepatitis, and drugs of abuse testing. The company recently submitted a 510(k) to FDA for the Saliva Sampler saliva collection device, which includes a "patented adequacy indicator" ("The Gray Sheet" June 6, In Brief)
You may also be interested in...
Partisan Politics Returns To US FDA Congressional Oversight
The US FDA has stood out as an agency that tends to draw broad bipartisan support amid a generally rancorous and divided Congress. A House hearing, however, may be a sign that those days are over.
GLP-1 Coverage Restrictions In Medicare Part D Surge As Demand For Obesity Drugs Grows
A major shift from unfettered coverage to prior authorizations was recorded by MMIT over the past year for the leading GLP-1/GIP agonist diabetes drugs. Public interest in using the drugs off label for weight loss drove the change.
Roche Gets Adjuvant ALK+ Lung Cancer To Itself With Alecensa Approval
The US FDA cleared Roche’s supplemental approval request for ALK inhibitor Alecensa in ALK-positive non-small cell lung cancer following tumor resection.